Concepedia

Julia Boshuizen

JB

Statistics

Publications

9

Citations

1.4K

H-Index

9

Active since

2013

Affiliations

Oncode Institute(Current)

The Netherlands Cancer Institute

Utrecht University

Genmab (Netherlands)

Julia Boshuizen is an author at Oncode Institute specializing in oncology, medicine, and molecular oncology.

Publications per year

2013–2024

9

Publications

9

BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency

Yuqiao Shen, Farah Rehman, Ying Feng et al. · Clinical Cancer Research · 2013 · 487 citations · Full text

Medicine, Oncology, Pharmacology +14

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold

David W. Vredevoogd, Thomas Kuilman, Maarten A. Ligtenberg et al. · Cell · 2019 · 263 citations · Full text

Medicine, Immunology, Oncology +14

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Julia Boshuizen, Louise A. Koopman, Oscar Krijgsman et al. · Nature Medicine · 2018 · 223 citations

Medicine, Oncology, Pharmacology +17

Cancer drug addiction is relayed by an ERK2-dependent phenotype switch

Xiangjun Kong, Thomas Kuilman, Aida Shahrabi et al. · Nature · 2017 · 161 citations · Full text

Medicine, Cancer Biology, Oncology +10

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Julia Boshuizen, David W. Vredevoogd, Oscar Krijgsman et al. · Nature Communications · 2020 · 123 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 9